Advertisement
U.S. markets open in 4 hours 37 minutes
Advertisement

Lucid Diagnostics Inc. (LUCD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.4700-0.0100 (-0.68%)
At close: 04:00PM EST
1.4600 -0.01 (-0.68%)
After hours: 07:03PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close1.4800
Open1.4700
Bid0.8000 x 1300
Ask2.3500 x 1000
Day's Range1.4400 - 1.4800
52 Week Range1.0400 - 2.0000
Volume23,832
Avg. Volume42,592
Market Cap63.465M
Beta (5Y Monthly)1.81
PE Ratio (TTM)N/A
EPS (TTM)-1.4100
Earnings DateNov 14, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.16
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LUCD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Lucid Diagnostics Inc.
    Daily – Vickers Top Insider Picks for 11/30/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • Insider Monkey

    PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript

    PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript November 15, 2023 Operator: Good day, and welcome to the PAVmed Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s remarks, there will be an opportunity to ask questions. [Operator Instructions] Please also note that today’s event […]

  • Insider Monkey

    Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript

    Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter 2023 Business Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note that this event is being recorded. I would now like to turn the conference over […]

  • PR Newswire

    Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts

    Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ( "PAVmed"), announced that the Company has strengthened and expanded its executive team with two industry veterans to support its critical market access and direct contracting efforts. Natalie S. Carfora joins Lucid as Vice President, Market Access, and James M. Fricchione as Vice President, Employe